Gamma‐globulin vs serum
Complications due to measles · susceptible children exposed to measles
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
309 questions · 325 findings · 45 reviews · Acute Respiratory Infections
No studies found 38 · 11.7%GRADE not reported 31 · 9.5%Very low 54 · 16.6%Low 78 · 24%Moderate 106 · 32.6%High 18 · 5.5%
Intervention not reported
VT‐IPD, ITT (random) ( · Children under two years of age
The intervention leads to lower VT‐IPD, ITT (random) ( (high certainty).
1 finding from 1 review
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia… 2009 · Cochrane Headline outcomes onlyRR 0.2 [0.1, 0.42]7 studies · 113044 participantsHigh
Intervention not reported
All serotypes‐IPD, ITT (random) ( · Children under two years of age
The intervention leads to lower all serotypes‐IPD, ITT (random) ( (high certainty).
1 finding from 1 review
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia… 2009 · Cochrane Headline outcomes onlyRR 0.42 [0.25, 0.71]7 studies · 113044 participantsHigh
Intervention not reported
X‐ray defined pneumonia, ITT (random) ( · Children under two years of age
The intervention probably leads to lower X‐ray defined pneumonia, ITT (random) ( (moderate certainty).
1 finding from 1 review
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia… 2009 · Cochrane Headline outcomes onlyRR 0.73 [0.64, 0.85]4 studies · 104755 participantsModerate
Intervention not reported
Clinical pneumonia, ITT (random) ( · Children under two years of age
The intervention probably leads to lower clinical pneumonia, ITT (random) ( (moderate certainty).
1 finding from 1 review
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia… 2009 · Cochrane Headline outcomes onlyRR 0.94 [0.91, 0.98]4 studies · 104755 participantsModerate
Intervention not reported
Number of ARTIs · children (age < 18 years) susceptible to acute respiratory tract infections (ARTIs)
1 finding from 1 review
- Immunostimulants for preventing respiratory tract infection in children 2006 · Cochrane Headline outcomes onlyno estimate extracted35 studies · 4060 participantsModerate
Intervention not reported
Percent difference in ARTIs · children (age < 18 years) susceptible to acute respiratory tract infections (ARTIs)
1 finding from 1 review
- Immunostimulants for preventing respiratory tract infection in children 2006 · Cochrane Headline outcomes onlyno estimate extracted35 studies · 4060 participantsModerate
Intervention not reported
Incidence of gastrointestinal adverse events · children (age < 18 years) susceptible to acute respiratory tract infections (ARTIs)
1 finding from 1 review
- Immunostimulants for preventing respiratory tract infection in children 2006 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 1457 participantsLow
Intervention not reported
Incidence of skin adverse events · children (age < 18 years) susceptible to acute respiratory tract infections (ARTIs)
1 finding from 1 review
- Immunostimulants for preventing respiratory tract infection in children 2006 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 1469 participantsLow